J Clin Outcomes Manage
Pharmacotherapy for posttraumatic stress disorder
Abstract Objective: To review pharmaceutical agents studied for the treatment of posttraumatic stress disorder (PTSD). Methods: Review of the literature. Results: Evidence exists that pharmacotherapy can provide relief for the 3 core symptom clusters present in PTSD: reexperiencing, avoidance/numbing, and hyperarousal. The selective serotonin reuptake inhibitors are considered first-line pharmacotherapy for PTSD, although results are conflicting with respect to treatment of combat-related PTSD. The addition of other medications may be required to address specific aspects of the symptom spectrum and to treat co-occurring psychiatric conditions. Conclusion: There is a need for additional randomized controlled trials to confirm the effectiveness of pharmacologic treatment of PTSD.
Clinical Review Article
Search the Turner White index to find abstracts of articles published in JCOM.